Revvity introduces GSP T1D 3plex kit for type 1 diabetes detection

Revvity has launched the GSP T1D 3plex kit, which aims to support population screening programmes for children at risk of developing T1D months or years before symptoms emerge. GSP T1D 3plex kit uses capillary dried blood spot samples and is processed on Revvity’s GSP instrument. The kit was developed to address the requirements of emerging national T1D screening programmes. Credit: ANDREI ASKIRKA/Shutterstock.com. Revvity has launched the GSP T1D 3plex kit, a fully automated, CE-IVDR-certified test intended to support population screening programmes for children at risk of developing type 1 diabetes (T1D) months or years before symptoms emerge. The multiplex autoantibody…

Source: Medical Device Network